Abstract
Nivolumab Combined with Brentuximab Vedotin for Relapsed/Refractory Primary Mediastinal Large B-Cell Lymphoma: Preliminary Results from the Phase 2 CheckMate 436 Trial
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have